Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This case report describes a rare instance of tuberculous lymphadenitis in a patient with systemic lupus erythematosus, highlighting the potential link between immune suppression and tuberculosis risk.

This review highlights various plant-based and herbal treatments that reportedly help prevent hair loss and encourage hair growth. It also explores the molecular mechanisms, identified plant compounds, recent technologies such as nanoarchitectonics, and patents related to hair growth promotion.

This case report describes a 21-year-old woman with systemic lupus erythematosus who developed tuberculous lymphadenitis, highlighting the increased risk of TB in patients on long-term immunosuppressive therapy.

This study found that dyslipidemia is prevalent in 64.8% of male patients with androgenetic alopecia at Dr. Ruth K.M Pfau Civil Hospital, Karachi, highlighting the need for further research to confirm these findings.

This study found a significant negative correlation between serum SHBG levels and androgenetic alopecia severity in women, but not in men, while no significant correlation was observed for testosterone, estradiol, dehydroepiandrosterone sulfate, and vitamin D levels with hair loss severity across genders.

In this study on male androgenetic alopecia, the researchers reported significant increases in hair count, density, and thickness with minimal side effects over 6 weeks using adipose-derived stem cell conditioned media and minoxidil, but found no significant differences between concentrated and non-concentrated treatments.

In this study, the Hamilton-Norwood subtype of female pattern hair loss was associated with early onset and polycystic ovary syndrome, while the Ludwig pattern was more common overall.

This review concluded that the efficacy of cosmeceutical hair serums for addressing hair loss lies in their use of bioactive peptides and plant compounds, like flavonoids and sterols, that target eight key contributing factors identified in hair loss conditions.

This case report describes a 21-year-old female with systemic lupus erythematosus who developed tuberculous lymphadenitis, which was attributed to her compromised immune system from long-term immunosuppressive therapy.

In this study, androgenetic alopecia in Nigerians was associated with dyslipidemia, alcohol intake, and sedentary lifestyle, with severity linked to age, systolic blood pressure, and obesity.

This report details a case of tuberculous lymphadenitis in a 21-year-old female with SLE, suggesting that immune suppression may increase susceptibility to this extra-pulmonary TB.

This case report describes a 21-year-old female with systemic lupus erythematosus who developed tuberculous lymphadenitis, highlighting the risk of TB in patients with weakened immune systems on long-term immunosuppressive therapy.

This case report details a 21-year-old female with systemic lupus erythematosus who developed tuberculous lymphadenitis, illustrating how immunosuppressive therapy in SLE patients can lead to such infections.

This article recounts Francisco Camacho Martinez's influential career and contributions in dermatology and reports no new clinical findings.

This study suggests an association between metabolic syndrome and androgenic alopecia severity, though this association was not statistically significant.

This case report describes a patient with psoriasis who developed vesiculobullous dermatitis on the palms and soles after starting treatment with secukinumab.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

In this study, androgenetic alopecia, diagonal earlobe crease, and hairy ear were more frequently observed in men with coronary artery disease compared to controls.

This review discusses the association between alopecia and increased cardiovascular and metabolic risk but reports no definitive clinical results, emphasizing the need for more comprehensive studies on androgenetic alopecia patients.

This study found that male patients with Androgenetic alopecia have higher serum leptin, lower vitamin D levels, and an altered adiponectin/leptin ratio, which may contribute to the disease's pathogenesis.

This study found no direct association between androgenetic alopecia and metabolic syndrome in the Chinese population, though AGA was closely linked with higher systolic blood pressure in men.

This review discusses the pathological factors and comorbidities associated with androgenetic alopecia and reports no new clinical results, emphasizing the need for improved understanding and treatment in clinical practice.

This study found that adding microneedling with low-level LED therapy and growth factors to Finasteride® treatment led to significant hair regrowth and increased hair density in patients with androgenic alopecia.

This review found a significant association between smoking and androgenetic alopecia, but notes a lack of studies on whether quitting smoking can improve hair loss.

This study found that psoriasis, acne, and androgenetic alopecia are associated with an atherogenic lipid profile, suggesting an increased risk of atherosclerosis and cardiovascular disease, especially among psoriasis patients.

This study found that men with early androgenetic alopecia had higher levels of free testosterone, DHEAS, and LH, along with insulin resistance and higher homocysteine levels, suggesting they share risk profiles similar to PCOS in women.

This study found that patients with early-onset androgenetic alopecia had significantly higher levels of fasting blood sugar, triglycerides, and cholesterol, suggesting an increased risk of developing coronary artery disease.

This study found a significant correlation between metabolic syndrome components, particularly waist circumference and hypertension, and female pattern hair loss.

In this study, androgenetic alopecia patients had a significantly higher prevalence of metabolic syndrome and related metabolic disorders compared to those without the condition.

This study concluded that patients with androgenetic alopecia may have a higher risk of cardiovascular diseases compared to people without this condition.